Durable Mechanical Circulatory Support versus Organ Transplantation: Past, Present, and Future

Figure 5

A comparison of 1-year survival with optimal medical therapy (REMATCH), pulsatile-flow VADs (LionHeart; XVE), and continuous-flow VADs (HMII; HVAD). The rise in survival echoes that newer technology along with improved management of VAD patients has led to an increased overall survival [17, 22, 49, 50].